News

Vical has announced that systematic in vivo testing of its Vaxfectin adjuvant shows that it increased antibody and T-cell responses primarily by stimulating the immune system rather than

The growing demand for generic pharmaceuticals as a means to expand access to affordable high-quality medicine and control healthcare costs will continue to drive the growth of the

Microbia, a producer of sustainable specialty ingredients and biomaterials, has achieved an important milestone in creating its line of naturally derived carotenoids for the food ingredient and nutritional

Hi-Tech Pharmacal (Hi-Tech) has received clearance from the FDA to market Tropazone lotion, a prescription dermatological product which is expected to be promoted by Hi-Tech’s branded marketing subsidiary,

Vivus has reported positive results from a phase 2 study evaluating the safety and efficacy of Qnexa, an investigational drug, for the treatment of obstructive sleep apnea (OSA).

Reata Pharmaceuticals (Reata) and Kyowa Hakko Kirin have entered into a licensing agreement that provides the latter with the exclusive rights to develop and commercialise Reata’s lead compound,

GeneGo has launched easy access to many Sigma Aldrich life science and chemistry products from their ‘Drug Details’ pages in three products: MetaCore 6.0, MetaDrug and Eureka. This

MediPEEK-IM advantages are biocompatibility, mechanical strength/toughness, superior hydrolysis and chemical resistance with dimensional stability, sterilizable and radio translucent with natural color. Modern Plastics is a distributor for Westlake

Gilead Sciences (Gilead) has reported that Phase II clinical trial of its investigational integrase inhibitor-based, once-daily, fixed-dose ‘Quad’ regimen of elvitegravir, GS 9350 and Truvada (emtricitabine and tenofovir